Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gynecology
  3. Postmenopause: the beneficial action of estradiol on the vaginal microbiota
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gynecology
  3. Postmenopause: the beneficial action of estradiol on the vaginal microbiota
Gynecology

Postmenopause: the beneficial action of estradiol on the vaginal microbiota

Menopause
Gynecology

Treating genitourinary symptoms of the menopause with vaginal estradiol appears to positively modify the vaginal microenvironment. Estradiol may have beneficial effects on the microbiota that are much more effective than simply treating symptoms.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
Photo: Postménopause : l'action bénéfique de l'estradiol sur le microbiote vaginal

About this article

Created 22 June 2022
Updated 29 June 2022

Vaginal dryness, pain, itching: postmenopause often comes with genitourinary symptoms. Vaginal estradiol or a moisturizing cream are frequently prescribed to relieve these symptoms, but the impact of these treatments on the vaginal microenvironment is poorly understood.

A comparative study

In 2016-2017, 302 postmenopausal women (average age 64) with moderate to severe vulvovaginal discomfort took part in the MsFLASH Vaginal Health Trial, a multicenter double-blind randomized clinical trial.

The aim :

The aim was to compare at 12 weeks the effect of a 0.01 mg vaginal estradiol tablet (+ a placebo gel) and a vaginal moisturizing gel (+ a placebo tablet) with a double placebo. While there was surprisingly no major difference in the reduction of symptoms experienced, at 12 weeks, more participants in the estrogen group had a vaginal pH of less than 5 and more than 5% superficial cells on VMI (Vaginal Maturation Index) than the placebo group.

Should these changes be interpreted as a beneficial effect on the vaginal environment beyond the mere improvement of symptoms? This is what the researchers sought to find out via a post-hoc analysis of a sub-group of 144 postmenopausal women.

Towards a healthier vaginal microbiota?

At 12 weeks, 80% of women in the estradiol group had vaginal bacterial communities dominated by Lactobacillus and Bifidobacterium, compared to only 36% in the moisturizer group and 26% in the placebo group.
Another change observed in the estradiol group was a change in the composition of vaginal fluid metabolites (significant changes for more than half of the 171 metabolites tested), including an increase in lactate, most certainly contributing to the additional decrease in pH in this group.
The effect of estradiol was more pronounced in women who initially had a very diverse vaginal microbiota (considered less healthy), a high vaginal pH, and a low VMI. Estradiol may therefore stimulate the metabolic activity of beneficial lactic acid-producing bacteria, such as lactobacilli and bifidobacteria.

Multiple findings

  • The use of vaginal estradiol tablets appears to result in profound changes to the vaginal microbiota and metabolome.
  • The benefits of the low pH moisturizer and the double placebo (lubricating effect) are limited to symptoms only.They show no significant impact on the vaginal microbiota or metabolome, despite the decrease in vaginal pH they bring about. 
  • This study shows that an identical reduction in pH following two different types of treatment does not necessarily reflect the same underlying biological effect, and that reducing the vaginal pH is not enough to modify the vaginal microbiota in postmenopausal women. According to the authors, this puts the value of pH-balanced gels into perspective.
Sources

Srinivasan S, Hua X, Wu MC et al. Impact of Topical Interventions on the Vaginal Microbiota and Metabolome in Postmenopausal Women: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 1;5(3):e225032.

Tags
Vaginal Menopause Women health Woman Oestradiol

en_view en_sources

    See also

    Actu PRO : Microbiote urinaire des femmes continentes : l’effet de l’âge Urinary microbiota in continent women: the effect of age
    Dysbiosis-related infections of the lower genital tract
    Created 22 June 2022
    Updated 29 June 2022

    About this article

    To know more about this topic.

    Main topic

    Menopause

    Medical practice

    Gynecology

    Content type

    News
    Gynecology

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Vaginal Microbiota # 16

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Vaginal microbiota # 14

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Vaginal Microbiota #15

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Urinary tract infections

    Infections of the lower urogenital tract are extremely common amongst women: seven out of ten women will su...

    Find out more

    Vaginal microbiota #10

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Targeting the gut microbiota to optimize vaccine efficacy?

    by Dr Genelle Healey

    Find out more

    The hygiene hypothesis and the COVID-19 pandemic

    by Dr Genelle Healey

    Find out more

    Continue reading

    News
    Cancer du col de l’utérus : l’étau se resserre sur L. iners
    14.02.2023

    Cervical cancer: the walls are closing in on L. iners

    Read the article
    Pregnancy: is vaginal dysbiosis responsible for complications in case of COVID-19?
    06.01.2023

    Pregnancy: is vaginal dysbiosis responsible for complications in case of COVID-19?

    Read the article
    Photo: WAAW 2022 (HCPs)
    25.10.2022

    Microbiota at the forefront of antibiotic resistance

    Read the article
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    Everything you need to know about Microbiota & Dysbiosis
    27.07.2022

    Everything you need to know about Dysbiosis

    Read the article
    Photo: Antibiotic resistance is a web of several problems (HCPs)
    02.11.2022

    Antibiotic resistance is a web of several problems

    Read the article
    Actu PRO : Une antibiothérapie prophylactique péri-partum appauvrit le lait maternel en Bifidobacterium
    12.03.2019

    Peripartum prophylactic antibiotic therapy decreases bifidobacterium levels in breast milk

    Read the article
    28.10.2021

    6 things you should know about antibiotics

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    L’axe intestin-cerveau dans le stress lié à la discrimination
    20.03.2023

    The gut-brain axis and discrimination-related stress

    Read the article
    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    14.03.2023

    Positive impact of running on gut microbiota and adolescent depression

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo